Aptivus (tipranavir oral solution, from Boehringer Ingelheim) has been approved for use in combination with ritonavir for treatment-experienced adults and pediatric patients 2-18 years of age infected ...

The oral solid dose drug was developed by a leading pharmaceutical company in the HIV treatment and prevention space, and represents the first FDA approval of Aptar’s proprietary Activ-Blister ™ ...

Treatment of the HIV/AIDS epidemic has seen remarkable advancements with the advent of the latest anti-retroviral drug therapy and powerful tools to test for drug resistance, making the infection ...

The Multiplo® TP/HIV rapid test allows healthcare professional to accurately detect both HIV-1/2 and syphilis antibodieswith one sample using a simple finger prick that delivers results immediately.

For the first time since HIV was identified, early human trials are starting to show what long‑imagined “drug‑free control” of the virus might look like in practice. Instead of chasing a total ...

The awarded solution integrates ABL’s Whole Genome HIV assays and bioinformatics software with ELTA 90’s Illumina-based NGS systems, providing a comprehensive and scalable workflow for high-precision ...

HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MIR:CA) (MedMira) announced today that it has received today, on December 24, 2024, the approval from Health Canada for its Multiplo ® ...